ProKidney Reports Business Updates and First Quarter 2024 Financial Results
May 10, 2024 07:00 ET
|
ProKidney
Final results from RMCL-002 Phase 2 trial to be presented in the Late Breaking Clinical Trials session at the European Renal Association (ERA) Congress on May 25, 2024. An investor call to provide a...
Gardner Syndrome Treatment Market Report 2024: Analysis and Forecast Through 2018-2033 Featuring Biochem Pharmaceuticals Industries, Zydus Lifesciences, Vernalis (R&D), Sun Pharmaceutical Industries, and Sanofi
April 24, 2024 04:09 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Gardner Syndrome Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global Gardner syndrome...
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
March 25, 2024 06:05 ET
|
ProKidney
Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufacturing of cell therapies Mr. Lucio Tozzi joined in...
GLP-1 Receptor Agonist Market on the Rise with Anticipated Surge to $16.82 Billion by 2028
January 29, 2024 10:48 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for GLP-1 receptor...
Gardner Syndrome Treatment Global Market Report 2023
July 04, 2023 09:48 ET
|
ReportLinker
New York, July 04, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gardner Syndrome Treatment Global Market Report 2023" -...
Press Release: Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients
June 13, 2023 08:00 ET
|
Sanofi - Aventis Groupe
Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients Paris, June 13, 2023. Sanofi takes the next step in its company-wide digital transformation and...
GLP-1 Receptor Agonist Global Market Report 2023
June 01, 2023 07:35 ET
|
ReportLinker
New York, June 01, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLP-1 Receptor Agonist Global Market Report 2023" -...
Immuno-Oncology (IO) Market is Expected to Reach the Valuation of USD 156.05 Billion by 2030, Size, Share, Growth, Trends, Demand and Opportunity Analysis
April 27, 2023 03:43 ET
|
Data Bridge Market Research
MELBOURNE, April 27, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research has unveiled a new report called "Immuno-Oncology (IO) Market" which provides an in-depth exploration of growth strategies,...
Press Release: Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to redefine expectations for treatment of children <12 years of age with hemophilia A
March 02, 2023 02:00 ET
|
Sanofi - Aventis Groupe
Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIO™ to redefine expectations for treatment of children <12 years of age with hemophilia A Paris, March 2, 2023. The...
Brain Tumor Drugs Global Market Report 2023
February 23, 2023 10:33 ET
|
ReportLinker
New York, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Brain Tumor Drugs Global Market Report 2023" -...